New developments in the search for treatments for Stargardt disease

Retina UK logo

10 March 2019
Source: Retina UK

Stargardt disease principally affects central vision, with onset usually occurring during adolescence or young adulthood, and is frequently caused by errors in a gene known as ABCA4. However, in many cases, no faults can be found in the sections of the gene that code for the building block ‘ingredients’ of the ABCA4 protein, meaning that there are no clues to

Read more New developments in the search for treatments for Stargardt disease

Survey for Stargardt patients

4 June 2018
Source: Macular Society

Genetic Alliance UK, a charity, which supports people living with genetic conditions, has produced a survey for people with Stargardt disease. The survey from Genetic Alliance UK, is looking to find out how the condition impacts those affected, their families and carers in their day to day lives. It is hoped the responses will help the organisation provide a vital patient

Read more Survey for Stargardt patients

Macular Society: Treatment trial for Stargardt diseases reaches the UK

12 February 2018
Source: Macular Society

Researchers in the south of England will become the first in the UK to trial a new drug that could prevent sight loss caused by Stargardt disease, a currently untreatable condition. Stargardt disease, also known as Stargardt macular dystrophy, affects the area of the retina called the macula and causes a reduction in central vision. It is the most common form of juvenile macular

Read more Macular Society: Treatment trial for Stargardt diseases reaches the UK